Dr. Reddy's Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 72,148 million compared to INR 67,700 million a year ago. Net income was INR 13,789 million compared to INR 12,471 million a year ago. Basic earnings per share from continuing operations was INR 82.81 compared to INR 75.09 a year ago. Diluted earnings per share from continuing operations was INR 82.68 compared to INR 74.95 a year ago.
For the nine months, sales was INR 208,334 million compared to INR 182,911 million a year ago. Net income was INR 42,614 million compared to INR 35,475 million a year ago. Basic earnings per share from continuing operations was INR 256.17 compared to INR 213.69 a year ago. Diluted earnings per share from continuing operations was INR 255.68 compared to INR 213.24 a year ago.